Abbott Nutritional Products — R&D increased by 3.8% to $54.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from $52.00M to $54.00M. Over 3 years (FY 2022 to FY 2025), Nutritional Products — R&D shows an upward trend with a 3.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher spending reflects a commitment to long-term innovation, whereas a significant decline might suggest a shift in strategy or cost-cutting measures.
Expenditures dedicated to the discovery, clinical testing, and development of new nutritional formulations and product e...
Standard R&D expense metric for life sciences and consumer health companies.
abt_segment_nutritional_products_research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.75M | $47.75M | $47.75M | $47.75M | $51.00M | $51.00M | $51.00M | $51.00M | $52.00M | $53.00M | $53.00M | $51.00M | $52.00M | $54.00M | $55.00M | $52.00M | $54.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.8% | +0.0% | +0.0% | +0.0% | +2.0% | +1.9% | +0.0% | -3.8% | +2.0% | +3.8% | +1.9% | -5.5% | +3.8% |
| YoY Change | — | — | — | — | +6.8% | +6.8% | +6.8% | +6.8% | +2.0% | +3.9% | +3.9% | +0.0% | +0.0% | +1.9% | +3.8% | +2.0% | +3.8% |